Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and patient education are crucial for managing alopecia areata.

CT60 polymorphism might increase the risk of Alopecia Areata.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

HLA-DRB5 and other genes may be linked to alopecia universalis.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Cannabinoids may help treat various skin conditions.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Genetic discoveries are leading to new treatments for alopecia areata.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Enzymes called PADIs play a key role in hair growth and loss.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.